Key Take-aways

• To define and measure the global top ten medical device technologies mainly by their high growth technologies, and also by products and applications wherever applicable
• To focus the macro markets and micro markets specifically on the basis of products, applications, and recent technologies which promise a huge growth potential in future
• To identify the key micro markets which are set to yield high profit margin, and expected to grow exponentially in the coming years, and their subsequent drivers for the growth
• To identify market trends, gaps and opportunities for all the stakeholders
• To strategically analyze the market structure and competitive landscape profiling in detail for all the top companies in all the micro markets of the identified top ten medical device technologies

MARKET COVERED

In the entire medical device industry, continuous innovations keep on happening, thus leading to radical transformation in patient care. Here in this report, we have tried identifying the sectors with the most important developments affecting patient care, clinical outcome, product development, and the device industry as a whole. Though we have tried covering all the important technologies under our report, but we might have missed few other equally important technologies as well, because the scope of the report was limited to ten technologies only. But, still we have covered almost the entire medical device market as a whole.

This report will analyze the market potential for the global top ten medical device technologies. The technologies are selected on the basis of the following factors in prioritized order:

• Technologies which cover a major share of the entire medical device market: Under each of these categories, the individual high growth micro technology markets are identified
• Technologies foreseeing a huge growth potential in coming four to five years (mainly the technologies having an annual growth rate of more than 10%)

The technologies being covered in the study are:

• Diagnostic imaging (nuclear imaging, interventional radiology, capsule endoscopy and others)
• Drug delivery (needle free injections, transdermal systems, inhalation system, infusion system)
• Molecular diagnostics (biosensors, proteomics, nanotechnology, and others)
• Mobility aid technologies
• Minimal/non m invasive surgery (stents, bariatric surgery, medical robotics and others)
• Micro-fluids and MEMS (Miniature medical pressure sensors, bio chips, protein chips)
• Non-invasive monitoring (continuous blood glucose monitoring)
• Biomaterials (bionic limbs, joint replacement, antimicrobial wound dressing and others)
• Bio-implants (neurostimulation and others)
• Tele-medicines

The existing studies and third-party market reports do not provide a comprehensive understanding of the global top ten medical device technologies market. The critical markets within this broader field are also not analyzed. This report not only provides a full market estimate of global top ten medical device technologies market; it also gives a detailed analysis of its most critical micro markets, which have so far remained unexplored.

In addition to the comprehensive information on the macro markets, it also covers the comparative analysis of the following technologies, which will provide a clear view to the stakeholders about the lifecycle and market attractiveness of each of these technologies:

• Technologies which were existing previously in place of the current technology
• Current technologies existing in the market
• Future alternatives to these technologies

REPORT DESCRIPTION

The report gives a full breakdown of the entire global top ten medical device technologies market on the basis of products, applications, technology, and end-users. Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. 

The report features more than 100 tables that give a complete insight into the market, along with 60 competitive company profiles. All market tables will be categorized by geographic region, product, application, technology, and end-user categories.

The report highlights strategic issues that how the global top ten medical device technologies will be able to cover up the already existing older technologies. This will also include consolidating strategy, new product development, competitive positioning, gap analysis and identification of opportunities and challenges. Niche opportunities are identified for both product and service sub-segments within these identified global top ten medical device technologies.

STAKEHOLDERS

The intended audience includes all the stakeholders of the global top ten medical device technologies market-

• Medical Device Manufacturers: The report defines the market size and forecast up to the year 2014 for each of the micro markets under the individual global top ten medical device technologies market. It also provides technology developments, competitive landscape and the profiles of the key players existing in the industry
• Hospital Surgical Departments: The report provides market information on new technologies and their market potential for the surgical devices in the medical devices market
• Clinical Research Firms: The report provides a comparative analysis of the various technologies which were prevailing in the past, the existing technologies, and the technologies which will replace these existing technologies
• Business research and consulting service providers: Business research and consulting firms will need this report to get the market and geographic data points for specific micro markets; and to identify the major players and their competitive landscape in this industry.

1.      Chapter one – introduction

2.      Chapter two – summary

3.      Chapter three – market overview

3.1.   Evolution of medical device technologies

3.2.   Defining the top ten medical device technologies market

3.3.   Patients' drift towards better quality of life leading to adoption of innovative medical devices

3.4.   Aging population over 65 dictates the market for medical devices

3.5.   Opportunity for medical device technologies lies in the less developed countries

3.6.   Extensive product recalls is a major challenge for the medical device industry

4.      Chapter four – diagnostic imaging

4.1.   Market drivers

4.1.1.      Emergence of new technology in diagnostic imaging

4.1.2.      Expansion in the applications of diagnostic imaging

4.1.3.      Aging demographics

4.1.4.      Preventative healthcare in demand

4.1.5.      Expansion of testing technologies coverage

4.2.   Restraints

4.2.1.      Slowdown in demand for medical imaging equipments due to economic turmoil

4.2.2.      Regulatory body initiatives to tighten the healthcare cost are slowing the sales of these devices

4.3.   Competitive landscape

4.4.   Mri systems

4.4.1.      Market drivers

4.4.1.1.   Wide variety of application

4.4.1.2.   Improvement in telsa strength

4.4.2.      Competitive landscape

4.5.   Ultrasound systems

4.5.1.      Market drivers

4.5.1.1.   Untapped demand of emerging market driving the growth of ultra sound system market

4.5.1.2.   Refurbished equipment market for ultrasound system is booming

4.5.1.3.   Increased use of ultrasound by emergency medical services and non-radiologists

4.5.2.      Restraints

4.5.2.1.   Saturation in core market limiting the sales for new ultrasound system

4.5.2.2.   Lack of clear and adequate reimbursement for new ultrasound capabilities

4.5.3.      Competitive landscape

4.6.   X-ray systems

4.6.1.      Market drivers

4.6.1.1.   Finer image quality

4.6.2.      Restraints

4.6.2.1.   Other advanced diagnostic imaging technologies hindering the growth of x-ray market

4.6.2.2.   Cost issues affecting the further spread of x-ray market

4.6.3.      Competitive landscape

4.6.3.1.   Merges and acquisitions for x-ray systems market

4.6.3.2.   Other developments for x-ray systems

4.7.   Mammography equipments

4.7.1.      Market drivers

4.7.1.1.   Increase in demand of digital mammography enhancing the growth opportunities for the mammography equipment due to advanced technology

4.7.1.2.   Favorable reimbursement scenario boosting the demand for the mammography equipment

4.8.   Tomography equipments

4.8.1.      Market drivers

4.8.1.1.   Introduction of higher slice ct scanner promising growth opportunities in the tomography market

4.8.1.2.   Increase in angiogram ct application is driving the growth of the market

4.8.1.3.   Optical coherence tomography (oct) is the new optics technology creating a significant niche in ophthalmology

4.8.2.      Restraints

4.8.2.1.   Shift from a slice count basis to detector coverage

4.8.2.2.   Mri moving ahead from ct scan

4.8.3.      Competitive development

4.9.   Nuclear imaging equipments

4.9.1.      Nuclear imaging getting widely accepted for early diagnosis of cardiology, cancer and neurological disorder

4.9.2.      Hybrid imaging modalities capturing the nuclear imaging equipments market

4.9.3.      Competitive landscape

4.9.4.      Other developments

4.10.                    Interventional radiology

4.10.1.  Market drivers

4.10.1.1.   Advances in medical instrumentation and in radiological imaging technology are driving the market for interventional radiology procedures

4.10.1.2.  Minimally invasive imaging procedures cardiac interventional and radiology vascular interventional radiology are gaining popularity

4.10.2.  Restraints

4.10.2.1.     Financial limitation put a stop to capital investment by the hospitals for interventional radiology

4.10.2.2.   Lack of professional radiologist affecting the interventional radiology market

4.10.3.  Competitive landscape

4.11.  Capsule endoscopy

4.11.1.  Market drivers

4.11.1.1.  Application of capsule endoscopy for gastrointestinal ailments diagnosis is picking up due to innovative design for colonic indications

4.11.1.2. Favorable move from fda further clearing the growth path for capsule endoscopy

4.11.2.  Competitive landscape

4.12.     Lasers – imaging

4.12.1.  Market drivers

4.12.1.1.   Reasonably priced lasers has marked its presence in medical fraternity

4.12.1.2.   A number of benefits expand the scope and opportunities for the laser technology

5.      Chapter five – Drug delivery devices

5.1.   Inhalation systems

5.1.1.      Market drivers

5.1.2.      Competitive landscape

5.2.   Infusion system

5.2.1.      Competitive landscape

5.3.   Needle-free injection/transdermal systems

5.3.1.      Market drivers

5.3.2.      Restraints

5.3.3.      Competitive landscape

6.      Chapter six – Medical diagnostics

6.1.   Market drivers

6.1.1.      Popularity of point of care (poc) and home health care driving the market for medical diagnostic

6.1.2.      The medical diagnostic is expected to expand due to rise in demand for genetic testing, esoteric testing and high end molecular diagnostic testing

6.2.   Restraints

6.2.1.      Factors such as economic slowdown, drugs abuse testing, test validation has affected the market momentum as confusion prevails among common public

6.3.   Biosensors

6.3.1.      Market drivers

6.3.1.1.   Increase in biosensor usage due to multiple applications leading to market growth of biosensors

6.3.1.2.   Population explosion and unhealthy lifestyles leading to the explosive demand for biosensors

6.3.1.3.   Miniaturization key to success for biosensors

6.3.2.      Restraints

6.3.2.1.   High cost involved in r&d of biosensors

6.4.   In vitro diagnostic (ivd)

6.4.1.      Market drivers

6.4.1.1.   Demand for the ivd in emerging markets

6.4.1.2.   Increase in worldwide aging population needing diagnostic services

6.4.1.3.   Increase in accessibility health care services by people

6.4.2.      Restraints

6.4.2.1.   Consolidation of hospital and commercial laboratories market and price pressure affecting the market growth

6.4.2.2.   Intense scrutiny by food and drug authority (fda) on ivd diagnostic market restraining the market

6.5.   Proteomics for molecular diagnostics

6.5.1.      Market drivers

6.5.1.1.   Proteomics: serving an opportunity for new drug and diagnostic market in terms of targeting more diseases

6.5.1.2.   Proteomics is a tool for analysis of pharmacological profiling, toxicity testing and drug’s effectiveness

6.5.1.3.   Enables detection of non communicable diseases

6.5.2.      Restraints

6.5.2.1.   The structuring of proteins needs expensive tools and machines leading to lower adoption rates

6.5.2.2.   Cost & reimbursement complexities emerging as major obstacles for the market

6.5.2.3.   Lack of technologies to speed up validation process

6.5.3.      Competitive landscape

6.5.3.1.   New product launch

6.6.   Nanotechnology for molecular diagnostics

6.6.1.      Market drivers

6.6.1.1.   Increase in demand of genetic screening, preimplantation screening and for the diagnosis of infectious diseases

6.6.2.      Opportunity

6.6.2.1.   Nanotechnology for cancer diagnostics showcasing promising future

6.6.3.      Restraint

6.6.3.1.   Lack of commercialization of nanotechnology medical devices

6.6.4.      Competitive landscape

6.6.4.1.   New product launch

6.6.4.2.   Other developments

6.7.   Pcr (polymerase chain reaction)

6.7.1.      Market drivers

6.7.1.1.   Potential to replace the conventional tests for infectious diseases, cancer diagnosis and genetic diseases

6.7.1.2.   Real- time pcr instrumentation clearance from fda is strengthening the clinical diagnostic market

6.7.2.      Restraint

6.7.2.1.   New technology, qpcr is replacing conventional pcr market

6.7.2.2.   Price sensitivity of pcr technology is area of concern for the end users

6.8.   Arrays

6.8.1.      Market drivers

6.8.1.1.   Demand for protein array on rise as it is facilitating drug discovery

6.8.1.2.   Classification of cancers done by micro array technology helping doctors to give appropriate treatment to the patients

6.8.1.3.   Minimal use of materials makes microarrays an inexpensive technology

7.      Chapter seven – mobility aid technologies

7.1.   Market drivers

7.1.1.      Aging population with mobility issues driving the market for mobility aid technology

7.1.2.      Demand for more independent life and assistance free daily living

7.1.3.      Popularization of physically challenged sports and recreation program

7.1.4.      Emergence of robotics technology in assistive device market

7.2.   Restraints

7.2.1.      Manual wheel chairs not suitable for people who suffer impairment of upper limbs

7.3.   Competitive landscape

7.4.   Global mobility aid technologies market by product types

7.4.1.      Wheelchairs and related devices

7.4.1.1.   Market drivers

7.4.1.1.1. Rise in population suffering from arthritis, arthrogryposis, osteoporosis etc.

7.4.1.1.2. Wide range of designs, materials, and configurations available in the market attracts users looking for the comfort

7.4.1.1.3. Increase in demand for power wheel chair because of more efficient mobility

7.4.1.2.   Restraints

7.4.1.2.1. Power dependence by powered wheel chair

7.4.1.2.2. Powered assist device more costly and less portable then manual wheel chair

7.4.1.2.3. Reimbursement issues with the powered wheelchairs

7.4.1.3.   Competitive landscape

7.4.1.4.   Manual wheelchairs

7.5.   Global mobility aid device market by technology

7.5.1.      Robotics

7.5.2.      Non robotics

7.5.3.      Walking-assist devices

7.5.3.1.   Market drivers

7.5.3.1.1. Changes in social trends like single parent and small family size creating demand for walking assist devices

7.5.3.1.2. More cases of cerebral palsy leading demand for more walking assist device to improve quality life

7.5.3.2.   Restraints

8.      Chapter eight – minimal invasive/non invasive surgery

8.1.   Market drivers

8.1.1.      Increase in aging population (65+) boosts the demand for surgeries

8.1.2.      Increase in demand of less risky operating methods

8.1.3.      Pressure to reduce heath care cost increases the market for minimal invasive surgery

8.1.4.      Lesser hospitalization period compared to conventional surgeries

8.1.5.      Higher rate of acceptance of minimal invasive surgery techniques

8.1.6.      Less painful and quicker recovery method of surgery compared open surgeries

8.2.   Restraints

8.2.1.      Limited number of surgeries performed with minimal invasive technique

8.2.2.      Special training and equipment is required to perform minimal invasive surgery

8.3.   Opportunities

8.3.1.      Huge market size attracting new entrants in minimal invasive market

8.3.2.      Physicians are setting a strong foundation for the future of minimal invasive surgery market

8.4.   Stent

8.4.1.      Market drivers

8.4.1.1.   Rise in cardio vascular diseases and access to conventional as well as hybrid cardiovascular procedures

8.4.1.2.   Rise in demand of minimal invasive heart surgeries

8.4.1.3.   Increase in number of obese and diabetic population world wide

8.5.   Medical robotics

8.5.1.      Market drivers

8.5.1.1.   Improved surgical results attracting more patients

8.5.1.2.   Shortening of surgical time is increasing the revenue of hospitals

8.5.1.3.   Improved surgeon ergonomics brings in accuracy

8.5.1.4.   Cost effectiveness

8.5.2.      Restraints

8.5.2.1.   Lack of human touch and intelligence

8.5.3.      Competitive landscape

8.6.   Light amplification by stimulated emission of radiation (lasers)

8.6.1.      Market drivers

8.6.1.1.   Growing awareness among people about laser technology has led to increased acceptance

8.6.1.2.   Rise in age-related diseases likely to enhance sales

8.6.2.      Developments

8.7.   Bariartic surgery

8.7.1.      Market drivers

8.7.1.1.   Growing number of overweight and obese population has increased the demand for surgeries

8.7.1.2.   Technological innovation with better and faster patient outcomes attracts patients

8.7.1.3.   Rising obesity among children expands the patient base

8.7.1.4.   Increase in awareness of obesity as a dangerous disease

9.      Chapter nine – micro- fluids chip and mems

9.1.   Market drivers

9.1.1.      Cost effective complex analysis system can be developed on a microfluidic (mf) chip

9.1.2.      Mf chip acts as an essential tool for mass spectrometry

9.1.3.      Complete automation in a single device leads to reduction in accidental loss of reagents

9.1.4.      Microchips enable greater speed & higher quality of output

9.1.5.      The minimal requirement of samples results in cost reduction

9.2.   Restraints

9.2.1.      Microfluidic chip technology unable to mix fluids on the chips in an effective manner, making them less favorable for analysis of complex fluids

9.2.2.      Lack of commercialization with respect to mems technology

9.3.   Miniature medical pressure sensors

9.4.   Biochips

9.4.1.      Market drivers

9.4.2.      Restraints

9.4.3.      Competitive landscape

9.4.3.1.   Other developments

9.5.   Dna chips

9.5.1.      Advances in microfluidics has strengthen the commercial potential of loc

9.5.2.      The demand for reduced sample size and reagent cost for new drug discovery has been major targeted areas of loc

9.5.3.      High development cost hampers the penetration of loc market

9.6.   Protein chips

9.6.1.      Competitive landscape

9.6.1.1.   Mergers and acquisitions for protein chips

9.6.1.2.   Other developments for protein chips

10.  Chapter ten – Non invasive monitoring

10.1.   Biosensors

10.1.1.  Wide scale acceptability of biosensors leading to deep penetration in the diagnostic market

10.1.2.  High cost involved in wide scale commercialization of biosensors restraining the growth of the market

10.1.3.  Continuous glucose monitoring

10.1.3.1.   Market drivers

10.1.3.1.1.  Emergence of diabetes as an epidemic worldwide has spurt the demand for continuous glucose monitoring

10.1.3.1.2.  Convenient usage of non invasive continuous glucose monitoring facilitating the market growth of continuous glucose monitoring

11.  Chapter eleven – Biomaterials

11.1.  Increase in aging population with a surge in age related orthopedic conditions will increase the demand for biomaterials

11.2. Cost- containment strategy and high degree of regulatory scrutiny by government is affecting the european and u.s. Market

11.3.  Applications of biomaterials

11.4.  Bionic limbs

11.5. Competitive landscape

11.6.  Bio-compatible materials

11.6.1.  Market drivers

11.6.1.1. Advancements in nanotechnology will boost the performance of bio-compatible ceramics

11.6.1.2.  Increase in demand of bio-compatible materials due to older population and demand from young people for highly functional requirements

11.6.2.  Vulcanized silicon based materials

11.6.3.  Joint replacement

11.6.3.1. Market drivers

11.6.3.1.1.  Rise in prevalence and incidences of orthopedic diseases in aging population

11.6.3.1.2.  Rise in the level of acceptability of bone grafts substitutes in wide range of application

11.6.3.2.   Restraints

11.6.3.2.1.  Rise in prices of titanium restraining the joint replacement market

11.6.3.2.2.  Modification in reimbursement policies affecting the joint replacement surgeries will affect the components used in joint replacement as well as surgeries

11.7. Antimicrobial wound dressing

11.7.1.  Market drivers

11.7.1.1. New products in anti microbial wound dressing are driving the growth potential of this market

11.7.1.2. Active demand of anti microbial wound dressing in the home health care

11.7.2.  Restraints

11.7.2.1.  Reluctance on part of physicians and nurses to adopt new products such that antimicrobial wound dressing

12.  Chapter twelve – Bio-implants

12.1.  Graft based implants

12.1.1.  Market drivers

12.1.1.1.   An increase in acceptance of graft based implants by medical practitioners

12.1.1.2.   Cosmetic surgery is gearing up due to the desire of beautiful personality

12.1.2.  Restraints

12.1.2.1. Expensive bone grafts

12.1.2.2.    Less interest shown by doctors to adopt new technique like bone graft

12.2.    Synthetic implants

12.2.1.  Market drivers

12.2.1.1.   Wide area of applications are driving the market of synthetic implants

12.2.1.2.    Good bio-compatibility of synthetic implants is making them a safe choice for implants

12.2.2.  Competitive landscape

12.2.3.  Neurostimulation

12.2.3.1.    Market drivers

12.2.3.1.1.  Rise in the aging population above 60+ (age) boosts the demand for neurostimulation market

12.2.3.1.2.  Increase in demand of less complicated operating methods and treatments

12.2.3.1.3.  Lesser treatment period as compared to old conventional surgeries

12.2.3.1.4.  Technological advancements

12.2.3.1.5.  The use of implantable neurostimulation devices in the treatment of the neurodisorders is increasing

12.2.3.2.   Restraints

12.2.3.2.1.  Special expertise is required to perform neurostimulation related surgeries

12.2.3.3.  Opportunities

12.2.3.3.1.  Physicians and surgeons are setting strong foundation for the future neurostimulation treatment

12.2.3.3.2.  Huge market size provides an opportunity for the growth of the market

12.2.3.4.    Spinal cord stimulation (scs)

12.2.3.4.1.  Market drivers

12.2.3.4.2.  Opportunities

12.2.3.4.3.  Competitive landscape

12.2.3.5.  Sacral nerve stimulation (sns)

12.2.3.5.1.  Market drivers

12.2.3.5.2.  Opportunities

12.2.3.6.    Vagus nerve stimulation (vns)

12.2.3.6.1.  Market drivers

12.2.3.6.2.  Opportunities

12.2.3.6.3.  Competitive landscape

12.2.3.7.     Deep brain stimulation systems

12.2.3.7.1.  Market drivers

12.2.3.7.2.  Restraints

12.2.3.7.3.  Opportunity

12.2.3.7.4.  Competitive landscape

13.  Chapter thirteen – Tele-medicines

13.1.   Hospitals

13.1.1.  Inpatient

13.1.2.  Outpatient

13.1.3.  Telemedicine vital signals (clinical health care signals)

13.1.4.  Telehealth

13.1.5.  Telehome

13.1.6.  Telehospital

13.2.   Key playing fields in telemedicine

13.2.1.  Market drivers

13.2.1.1.    Changing healthcare paradigm – inevitable need for telemedicine

13.2.1.2.   Increasing chronic diseases

13.2.1.3.    The healthcare network has turned complex

13.2.1.4.    Rising cost of home care

13.2.1.5.    Increasing aging patients requiring daily care

13.2.1.6.     Higher spending on it

13.2.1.7.     Moving from treatment to early intervention

13.2.2.  Restraints

13.2.2.1.   Technical

13.2.2.2.   Financial

13.2.2.2.1.  Doubts on the self-sustaining ability of the telemedicine model

13.2.2.2.2.  Reimbursement will decide the future of telemedicine

13.2.2.2.3.  Lack of funding of telemedicine programs

13.2.3.  Operational and social

13.2.3.1.  Lack of training

13.2.3.2.   Awareness and penetration

13.2.4.  Telemedicine technology

13.2.4.1.   Hardware

13.2.4.2.    Software

13.2.4.3.     Telecom and network

13.2.4.3.1.  Telecom and networking market

13.2.4.3.2.  Telehome t&n market

13.2.4.3.3.  Telehospital/clinics t&n market

14.  Chapter fourteen –  Top ten medical device technologies patent analysis

14.1.  General trends

15.  Chapter fifteen - Company profiles

15.1.  Abbott laboratories

15.1.1.  Overview

15.1.2.  Strategies and developments

15.2.   Atrium medical corporation

15.2.1.  Overview

15.2.2.  Strategies and developments

15.3. Boston scientific

15.3.1.  Overview

15.3.2.  Strategies

15.3.3.  Developments

15.4.  Barosense, inc

15.4.1.  Overview

15.5.   Berchtold gmbh

15.5.1.  Overview

15.5.2.  Berchtold corporation product portfolio

15.6.  Conor medsystems, llc

15.6.1.  Overview

15.6.2.  Strategies

15.6.3.  Developments

15.7.                    Celonova biosciences inc

15.7.1.  Overview

15.7.2.  Product portfolio of celenova

15.7.3.  Strategies

15.7.4.  Developments

15.8.                    Ethicon endo-surgery

15.8.1.  Overview

15.8.2.  Strategies

15.9.                    Intromedic

15.9.1.  Overview

15.9.2.  Developments

15.10.                Hitachi medical corporation

15.10.1.                      Overview

15.10.2.                      Strategy

15.10.3.                      Latest developments

15.11.                Given imaging

15.11.1.                      Overview

15.11.2.                      Strategy

15.11.3.                      Developments

15.12.                Ge medical systems

15.12.1.                      Overview

15.12.2.                      Proteus xr/a

15.12.3.                      Silhouette vr

15.12.4.                      Recent developments

15.13.                Biomet, inc

15.13.1.                      Overview

15.13.2.                      Recent developments

15.14.                Siemens medical solutions

15.14.1.                      Overview

15.14.2.                      Recent developments

15.15.                Xtent, inc.

15.15.1.                      Overview

15.15.2.                      Recent developments

15.15.3.                      Product portfolio

15.16.                Valleylab

15.16.1.                      Overview

15.17.                Terumo medical corporation

15.17.1.                      Overview

15.17.2.                      Recent developments

15.18.                Miv therapeutics, inc.

15.18.1.                      Overview

15.18.2.                      Recent developments

15.19.                Orbusneich

15.19.1.                      Overview

15.19.2.                      Recent developments

15.20.                Stentys s.a.s.

15.20.1.                      Overview

15.20.2.                      Recent developments

15.21.                Medinol ltd.

15.21.1.                      Overview

15.21.2.                      Recent developments

15.22.                Prosurgics

15.22.1.                      Overview

15.22.2.                      Recent developments

15.23.                Roche

15.23.1.                      Overview

15.23.2.                      R&d innovations

15.23.3.                      Blockbuster products

15.24.                Olympus

15.24.1.                      Overview

15.24.2.                      Recent developments

15.25.                Medtronic, inc.

15.25.1.                      Overview

15.25.2.                      Recent developments

15.26.                Scientific intake

15.26.1.                      Overview

15.26.2.                      Product

15.26.3.                      Overview

15.26.4.                      Recent developments

15.26.5.                      Product

15.27.                Metacure nv

15.27.1.                      Overview

15.27.2.                      Developments

15.27.3.                      Product

15.28.                Leptos biomedical, inc.

15.28.1.                      Overview

15.28.2.                      Technology

15.29.                Hologic, inc.

15.29.1.                      Overview

15.30.                Smith & nephew

15.30.1.                      Overview

15.30.2.                      Recent developments

15.30.3.                      Products

15.31.                Integrated surgical systems inc (acquired by curexo technologies)

15.31.1.                      Overview

15.31.2.                      Recent developments

15.32.                Allergan

15.32.1.                      Overview

15.32.2.                      Developments

15.33.                Enteromedics

15.33.1.                      Overview

15.33.2.                      Recent developments

15.33.3.                      New products for enteromedics

15.34.                Hélioscopie sa

15.34.1.                      Overview

15.35.                Karl-storz

15.35.1.                      Recent developments

15.36.                Esaote spa (a subsidiary of braco biomed spa)

15.36.1.                      Overview

15.36.2.                      Recent developments

15.37.                Stryker

15.37.1.                      Overview

15.37.2.                      Recent developments

16.  Chapter sixteen – appendix

16.1.                    U.s. Patents

16.2.                    European patents

16.3.   Japanese patents

 

List of Tables

1. GLOBAL top ten device technologies MARKET 2007 – 2014 ($ MILLIONS)
2. GLOBAL DIAGNOSTIC IMAGING MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
3. GLOBAL DIAGNOSTIC IMAGING MARKET by geography  THROUGH 2014  ($ Millions)
4. MERGERS AND ACQUISITIONS FOR DIAGNOSTIC IMAGING MARKET
5. NEW PRODUCT launch FOR DIAGNOSTIC IMAGING MARKET
6. GLOBAL MRI SYSTEMS MARKET BY GEOGRAPHY  THROUGH 2014  ($ MILLIONS)
7. MERGERS AND ACQUISITIONS FOR MRI MARKET
8. NEW PRODUCT LAUNCH FOR MRI MARKET
9. REGULARITY APPROVAL FOR MRI MARKET
10. OTHER DEVELOPMENTS FOR MRI MARKET
11. Global ULTRASOUND SYSTEMS market by geography  THROUGH 2014  ($ Millions)
12. NEW PRODUCT LAUNCH FOR ULTRASOUND SYSTEMS MARKET
13. REGULAtory APPROVALs FOR ULTRASOUND SYSTEMS MARKET
14. Global X-RAY SYSTEMS market by geography  THROUGH 2014  ($ Millions)
15. new product launch for X-RAY SYSTEMS
16. REGULARITY APPROVAL FOR X-RAY SYSTEMS
17. Global MAMMOGRAPHY EQUIPMENTS market by geography  THROUGH 2014  ($ Millions)
18. MERGERS AND ACQUISITIONS FOR MAMMOGRAPHY EQUIPMENTS MARKET
19. NEW PRODUCT LAUNCH FOR MAMMOGRAPHY EQUIPMENTS MARKET
20. REGULATORY APPROVAL FOR MAMMOGRAPHY EQUIPMENTS MARKET
21. Global TORNOGRAPHY EQUIPMENTS market by geography  THROUGH 2014  ($ Millions)
22. new product launch FOR TOMOGRAPHY EQUIPMENTS MARKET
23. REGULATORY APPROVAL FOR TOMOGRAPHY EQUIPMENTS MARKET
24. Global NUCLEAR IMAGING EQUIPMENTS market by geography  THROUGH 2014  ($ Millions)
25. NEW PRODUCT LAUNCH FOR NUCLEAR IMAGING EQUIPMENTS MARKET
26. Global INTERVENTIONAL RADIOLOGY market by geography  THROUGH 2014  ($ Millions)
27. NEW PRODUCT LAUNCH FOR INTERVENTIONAL RADIOLOGYS MARKET
28. Global CAPSULE ENDOSCOPY MARKET by geography  THROUGH 2014  ($ Millions)
29. NEW PRODUCT LAUNCH FOR CAPSULE ENDOSCOPY MARKET
30. Global LASERS – IMAGING MAKRET by geography  THROUGH 2014  ($ Millions)
31. GLOBAL DRUG DELIVERY DEVICES MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
32. Global DRUG DELIVERY DEVICES market by geography  THROUGH 2014  ($ Millions)
33. Global INHALATION SYSTEMS market by Product THROUGH 2014  ($ Millions)
34. NEW PRODUCT LAUNCH FOR INHALATION SYSTEMS MARKET
35. REGULATORY APPROVAL FOR INHALATION SYSTEMS MARKET
36. Global INFUSION SYSTEM MARKET by geography  THROUGH 2014  ($ Millions)
37. NEW PRODUCT LAUNCH FOR INFUSION SYSTEM MARKET
38. REGULATORY APPROVAL FOR INFUSION SYSTEM MARKET
39. other developments FOR INFUSION SYSTEMS MARKET
40. Global NEEDLE-FREE INJECTION/TRANSDERMAL SYSTEMS MARKET by geography  THROUGH 2014  ($ Millions)
41. REGULATORY APPROVAL FOR NEEDLE-FREE INJECTION/TRANSDERMAL SYSTEMS MARKET
42. Global MEDICAL DIAGNOSTICS market by Product THROUGH 2014  ($ Millions)
43. GLOBAL MEDICAL DIAGNOSTICS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
44. GLOBAL BIOSENSORS MARKET BY geography   THROUGH 2014 ($ MILLIONS)
45. NEW PRODUCT LAUNCH FOR BIOSENSOR MARKET
46. Global IVD market by geography  THROUGH 2014  ($ Millions)
47. GLOBAL PROTEOMICS FOR MOLECULAR DIAGNOSTICS MARKET BY GEOGRAPYH THROUGH 2014 ($ MILLIONS)
48. GLOBAL NANOTECHNOLOGY FOR MOLECULAR DIAGNOSTICS MARKET BY GEOGRAPYH THROUGH 2014 ($ MILLIONS)
49. REGULATORY APPROVAL FOR NANOTECHNOLOGY MARKET
50. GLOBAL PCR MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
51. NEW PRODUCT DEVELOPMENTS FOR PCR MARKET
52. GLOBAL ARRAYS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
53. GLOBAL MOBILITY AID TECHNOLOGIES MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
54. GLOBAL MOBILITY AID TECHNOLOGIES MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
55. MERGERS AND ACQUISITIONS FOR MOBILITY AID TECHNOLOGIES MARKET
56. GLOBAL POWERED WHEELCHAIRS DEVICES MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
57. GLOBAL SCOOTERS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
58. GLOBAL STAIR LIFTS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
59. GLOBAL MANUAL WHEELCHAIRS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
60. NEW PRODUCT DEVELOPMENT FOR POWERED WHEELCHAIRS MARKET
61. NEW PRODUCT DEVELOPMENT FOR MANUAL WHEELCHAIRS MARKET
62. GLOBAL Mobility aid device MARKET BY technologY THROUGH 2014 ($ MILLIONS)
63. GLOBAL ROBOTICS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
64. GLOBAL NON-ROBOTICS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
65. Global Medical Robotics market by ProducT THROUGH 2014 ($ Millions)
66. Global Medical Robotics market by Geography THROUGH 2014 ($ Millions)
67. NEW PRODUCT DEVELOPMENt OF MEDICAL ROBOTICS
68. fda approvals for MEDICAL ROBOTICS
69. AGREEMENTS for MEDICAL ROBOTICS MARKET
70. mergers and acquisitions in MEDICAL ROBOTICS MARKET
71. partnerships in MEDICAL ROBOTICS MARKET
72. Global Lasers market by Geography THROUGH 2014 ($ Millions)
73. new product developments of lasers MARKET
74. FDA approval of laserS
75. AGREEMENTS for LASERS MARKET
76. Global market for obesity SURGERY MARKET BY geography Through 2014 ($ Millions)
77. GLOBAL MICRO-FLUIDS AND MEMS MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
78. GLOBAL MICRO-FLUIDS AND MEMS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
79. Global Miniature Medical Pressure Sensors MARKET by GEOGRAPHY THROUGH 2014  ($ Millions)
80. GLOBAL BIOCHIPS MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
81. GLOBAL BIOCHIPS BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
82. NEW PRODUCT DEVELOPMENTS FOR BIOCHIPS MARKET
83. GLOBAL DNA CHIPS MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
84. GLOBAL DNA CHIPS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
85. GLOBAL PROTEIN CHIPS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
86. Global NON INVASIVE MONITORING market by Product THROUGH 2014  ($ Millions)
87. Global NON INVASIVE MONITORING market by GEOGRAPHY THROUGH 2014  ($ Millions)
88. Global NON INVASIVE BIOSENSORS market by Product THROUGH 2014  ($ Millions)
89. Global NON INVASIVE BIOSENSORS market by GEOGRAPHY THROUGH 2014  ($ Millions)
90. GLOBAL CONTINUOUS GLUCOSE MARKET MONITORING BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
91. GLOBAL BIOMATERIALS MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
92. GLOBAL BIOMATERIALS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
93. GLOBAL BIONIC LIMBS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
94. NEW PRODUCT LAUNCH FOR BIONIC LIMBS MARKET
95. GLOBAL BIO-COMPATIBLE MATERIALS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
96. GLOBAL VULCANIZED SILICON BASED MATERIALS MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
97. GLOBAL VULCANIZED SILICON BASED MATERIALS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
98. GLOBAL JOINT REPLACEMENT MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
99. GLOBAL ANTIMICROBIAL WOUND DRESSING MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
100. NEW PRODUCT LAUNCH FOR ANTIMICROBIAL WOUND DRESSING MARKET
101. REGULATORY APPROVAL FOR ANTIMICROBIAL WOUND DRESSING MARKET
102. GLOBAL BIOIMPLANTS MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
103. GLOBAL BIOIMPLANTS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
104. GLOBAL GRAFT BASED IMPLANTS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
105. GLOBAL SYNTHETIC IMPLANTS MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
106. GLOBAL SYNTHETIC IMPLANTS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
107. MERGERS AND ACQUISITIONS FOR DIAGNOSTIC IMAGING MARKET
108. NEW PRODUCT LAUNCH FOR SYNTHETIC IMPLANTS MARKET
109. REGULATORY APPROVAL FOR SYNTHETIC IMPLANTS MARKET
110. GLOBAL Neurostimulation MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
111. GLOBAL Neurostimulation MARKET BY Geography THROUGH 2014 ($ MILLIONS)
112. GLOBAL Spinal cord stimulation MARKET BY Geography THROUGH 2014 ($ MILLIONS)
113. REGULATORY APPROVAL FOR VNS MARKET
114. TABLE X  GLOBAL TELEMEDICINE TECHNOLOGY MARKET 2007 – 2014 ($ MILLIONS)
115. TELEMEDICINE HARDWARE MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLIONS)
116. Telemedicine software market forecast (Telehome and telehospital/clinics) 2007-2014  ($ MILLIONS)
117. Table 29  telemedicine software geographic market forecast 2007-2014  ($ MILLIONS)
118. telehome software geographic market forecast 2007-2014  ($ MILLIONS)
119. telehospital/clinics software market forecast BY GEOGRAPHY 2007-2014  ($ MILLIONS)
120. NEW PRODUCT LAUNCH FOR TELEM EDICINE SOFTWARE MARKET
121. Table 34  TelemedIcine Telecom & networking (telehome and telehospital/clinics) market forecast 2007-2014  ($ millions)
122. T&N Geographic market forecast 2007-2014  ($ millions)
123. Telehome t&N geographic market forecast 2007-2014  ($ millions)
124. Telehospital/clinics t&N geographic market forecast 2007-2014  ($ millions)
125. Table 97  Number of Top ten medical device technologies PATENTS from 2004 to June 2009
126. ATRIUM MEDICAL CORPORATION PRODUCT PORTFOLIO
127. BOSTON SCIENTIFIC PRODUCT PORTFOLIO
128. CONOR MEDSYSTEMS PRODUCT PORTFOLIO
129. HITACHI MEDICAL CORPORATION Product portfolio
130. Given IMAGING Product portfolio
131. GE Medical Systems PRODUCT PORTFOLIO
132. Biomet PRODUCT PORTFOLIO
133. Siemens Healthcare PRODUCT PORTFOLIO
134. Table X  Product Portfolio for Xtent, Inc.
135. Valleylab PRODUCT PORTFOLIO
136. Terumo Medical PRODUCT PORTFOLIO
137. MIV Therapeutics PRODUCT PORTFOLIO
138. OrbusNeich PRODUCT PORTFOLIO
139. Stentys PRODUCT PORTFOLIO
140. Medinol PRODUCT PORTFOLIO
141. Prosurgics PRODUCT PORTFOLIO
142. Roche PRODUCT PORTFOLIO
143. Medtronic PRODUCT PORTFOLIO
144. Smith & Nephew PRODUCT PORTFOLIO
145. Intuitive Surgical PRODUCT PORTFOLIO
146. Table X  Pipeline Products for Allergan (present R&D status for obesity intervention)
147. Table X  New Products for Allergan
148. Helioscopie PRODUCT PORTFOLIO
149. Karl Storz PRODUCT PORTFOLIO
150. Esaote PRODUCT PORTFOLIO
151. Stryker PRODUCT PORTFOLIO

List of Figure

1. Mapping the value chain of Medical device market
2. Global top ten medical device technologies market – revenue by categories
3. Market share vs market growth matrix for the top ten medical device technologies market *
4. Increasing share of older population in least developed regions
5. Telemedicine market drivers
6. Telemedicine - key to collaborative health care
7. Top ten medical device technologies patents filed For different geographies From 2004 to June 2009
8. Top ten medical device technologies patents filed Worldwide for different categories from 2004 to June 2009
9. Top ten medical device technologies patents filed in US From 2004 to June 2009
10. Top ten medical device technologies PATENTS filed in Europe From 2004 to June 2009
11. Top ten medical device technologies patents filed in Japan from 2004 to June 2009

Scientific and medical technology breakthroughs – such as minimally invasive surgery (MIS) – have accelerated the accuracy of clinical outcomes and have also reduced recovery times and the medical costs borne by patients. This has led to radical transformation in patient care. This report identifies the sectors with the industry’s most important developments related to patient care, clinical outcomes, and new product development. While the scope of the report is limited to the top ten technologies only, it covers almost the entire medical device market.

IT integration in medical imaging and medical devices has given a significant boost to the healthcare industry, a trend that is apparent in the market growth of drug eluting stents and telemedicine technologies. The markets covered in the report have a current potential of $454.3 billion and are expected to grow at a CAGR of 9.8% between 2009 and 2014.

In 2009, the entire market for top ten medical device is estimated to be approximately $454.3 billion, of which medical diagnostic devices technologies alone constitute about 40% of the entire market at approximately $177.8 billion. The market for drug delivery devices constituted an estimated $110.8 billion for the same period.

The major driving factors in the home healthcare market is the patients’ drift towards a better quality of life, which has sped up the adoption of innovative medical devices; and has also accelerated IT integration in medical imaging and medical devices. However, the market opportunity for medical device technologies lies in the less developed countries.

Mobility aid technologies, micro-fluids and MEMS, tele-medicines and biomaterials are the fastest-growing medical device technologies at CAGRs of 20.7%, 19.7%, 14.2% and 12.9% respectively from 2009 to 2014. Of these, biomaterials shows huge potential because of its relatively bigger market size, with an estimated $46.6 billion in 2009 and $85.5 billion in 2014. The antimicrobial wound dressing segment is the fastest-growing biomaterials market, with an estimated size of $330 million in 2009 and $780 million in 2014.

Market estimates and forecast

The report provides in-depth market estimates and forecast for the top ten medical device technologies as follows:

• Diagnostic imaging (nuclear imaging, interventional radiology, capsule endoscopy and others)
• Drug delivery (needle free injections, transdermal systems, inhalation system, infusion system)
• Molecular diagnostics (biosensors, proteomics, nanotechnology, and others)
• Mobility aid technologies
• Minimal/non-invasive surgery (stents, bariatric surgery, medical robotics and others)
• Micro-fluids and MEMS (Miniature medical pressure sensors, bio chips, protein chips)
• Non-invasive monitoring (continuous blood glucose monitoring)
• Biomaterials (bionic limbs, joint replacement, antimicrobial wound dressing and others)
• Bio-implants (neurostimulation and others)
• Tele-medicines